This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
CRH coordinates stress responses through CRHR1/CRHR2 in hypothalamic and extrahypothalamic brain regions, with dysregulation linked to depression, anxiety, addiction, and neurodegeneration, making CRHR1 a therapeutic target.
Why it matters
Stress-related mental health disorders affect billions of people. Understanding the CRH system provides targets for new treatments that address the root biology of these conditions rather than just symptoms.
The numbers in context
2 receptors (CRHR1, CRHR2); HPA axis + extrahypothalamic pathways; linked to depression, anxiety, addiction, Alzheimer's; CRHR1 antagonists as potential antidepressants; CRH regulates brain structure
How the study worked
Narrative review of CRH system biology, receptor pharmacology, stress pathway mechanisms, and involvement in psychiatric and neurodegenerative disorders.
Who was studied
Review of CRH system biology, receptor pharmacology, and involvement in stress and psychiatric disorders
What this study cannot tell us
Review based on animal and human studies of varying quality. CRHR1 antagonists have not yet proven effective in clinical trials. The complexity of the CRH system makes targeted intervention challenging.
Read the original research
The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response.
Vavilovskii zhurnal genetiki i selektsii, 25(2), 216-223
Citation
Sukhareva, E V. (2021). The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response.. Vavilovskii zhurnal genetiki i selektsii, 25(2), 216-223. https://doi.org/10.18699/VJ21.025